Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Pfizer to acquire Seagen for $43B

“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate technology with the scale and strength of Pfizer’s capabilities and expertise," says Pfizer Chairman and CEO Albert Bourla, PhD.

Thumbnail

Former CEO indicted for fake medical device implanted in patients

Laura Perryman, the former chief of Florida-based Stimwave, allegedly created a non-functioning “dummy device” that was used to treat patients suffering from chronic pain.

Oversight Committee launches investigation into pharmacy benefit managers

CVS Caremark, Express Scripts and OptumRx have been asked to provide documents, communications and information related to their practices.

FDA seeking upwards of $7B for 2024

The Food and Drug Administration has put in for a $7.2 billion chunk of the $6.9 trillion federal budget for fiscal year 2024 that President Joe Biden proposed March 9.

Biden’s budget: Extend Medicare solvency through higher taxes on rich, more drug price changes

Biden says his proposals are an extension of what he has already accomplished to reduce the deficit and lower healthcare spending.

layoffs staff cuts termination workforce

Akorn Pharmaceuticals shuts down, lays off all employees

In a sudden "shock," Akorn Pharmaceuticals is closing all U.S. sites and laying off its entire workforce after failing to find a potential buyer.

files paperwork work load

FTC fines BetterHelp $7.8M, says the company 'betrayed' users for profit

BetterHelp is in hot water after the Federal Trade Commission slapped the online counseling service company with a $7.8 million fine and a proposed ban from sharing consumers’ health data.

Thumbnail

DEA proposes restricting some telemedicine prescriptions

The proposed rules specifically narrow the prescribing of controlled substances via telemedicine for patients who have not been seen in person.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”